Kiromic BioPharma completes expansion of manufacturing lab to support clinical trials


The 34,000-square-foot facility will allow Kiromic BioPharma to begin a cell therapy clinical trial for a product candidate by the end of the year.

Previous Atrium Health Wake Forest Baptist’s Comprehensive Cancer Center receives $3.1 million NIH grant to study heart damage in breast cancer patients
Next Schlafly inks joint venture with non-alcoholic craft brewer Wellbeing Brewing